Kenvue Debuts on Fortune 500 List | KVUE Stock News

Jun 02, 2025

Kenvue Inc. (KVUE, Financial) debuts on the Fortune 500 list, ranking at number 281.
The company reported 2024 full-year sales of $15.5 billion.
Kenvue operates in over 165 countries, reaching approximately 1.2 billion people daily.

Kenvue Inc. (KVUE), the maker of popular consumer health products such as Tylenol®, Neutrogena®, and Listerine®, has made its first appearance on the Fortune 500 list, ranking at number 281. This achievement follows Kenvue's transition to a fully independent company, with impressive 2024 full-year sales totaling $15.5 billion.

According to Thibaut Mongon, Chief Executive Officer of Kenvue, the recognition is a significant milestone for the company. "Being named to the Fortune 500 list validates the hard work and dedication of our Kenvuers," stated Mongon. "We are honored to join this elite group of companies and look forward to continuing our journey of growth and impact."

With operations in over 165 countries, Kenvue's extensive portfolio includes Essential Health, Self Care, and Skin Health & Beauty brands. The company reaches approximately 1.2 billion people daily, supported by a global workforce exceeding 20,000 employees. Kenvue is set to leverage its new status as a Fortune 500 company to further drive its mission of advancing consumer health through science-backed innovation and insights.

The Fortune 500 list, now in its 71st year, annually ranks the largest U.S. companies by total revenue. Kenvue's inclusion marks a new chapter in its journey, aiming to expand its influence in the wellness sector and solidify its position as a global leader in consumer health.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.